Industry: Healthcare Region: Denmark Transaction Price: USD 1 million Transaction Method: Equity Investment
Project introduction:
A Danish company, founded in 1923, is a health care company, aiming at finding more effective treatments for patients with diabetes and other serious chronic diseases. At present, the research areas of diseases include type 1 diabetes, type 2 diabetes, obesity, growth disorders, hemophilia, sickle cell anemia, nonalcoholic steatohepatitis, etc. The products include drugs for the above diseases, as well as insulin pens, growth hormone pens and various injection needles.
Cooperation mode:
Looking for partners who are interested in this technology to jointly promote cooperation in various forms such as distribution agency and technical cooperation.